114 results
8-K
EX-99.1
MTEM
Molecular Templates Inc
21 Apr 11
Other Events
12:00am
justice to John’s tremendous contributions to Threshold and the biotech community. We will at that time also provide an update on how the company
8-K
EX-99.1
MTEM
Molecular Templates Inc
19 Mar 12
Threshold Pharmaceuticals' TH-302 Receives Orphan Drug Designation in the European Union for the Treatment of Soft Tissue Sarcoma
12:00am
made available by the Community and by the Member States to support research into and development of orphan drugs. If the product is approved
8-K
EX-10.25
MTEM
Molecular Templates Inc
17 Mar 06
Entry into a Material Definitive Agreement
12:00am
of this Agreement his or her consent to be bound by the terms herein as to his or her interests, whether as community property or otherwise, if any, in the Shares hereby purchased.
Purchaser’s Spouse
8-K
EX-99.1
MTEM
Molecular Templates Inc
9 Oct 14
Other Events
12:00am
, or clinical validation, and we may have difficulties gaining market acceptance of the use of [18F]-HX4 in the clinical or medical community. Because [18F … physicians, patients, healthcare payors and the medical community. The degree of market acceptance of any approved products will depend on a number of factors